Peds Metabolic Syndrome in Psoriasis
NCT00930592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2019-04-16
Summary
The objective of this study is to assess whether there is an increased risk of the metabolic syndrome in children with psoriasis compared to children without psoriasis.
Conditions
- Psoriasis
- Metabolic Syndrome
Sponsors & Collaborators
- collaborator INDUSTRY
-
Tufts Medical Center
lead OTHER
Principal Investigators
-
Alice B. Gottlieb, M.D., PhD. · Tufts Medical Center, Department of Dermatology
Eligibility
- Min Age
- 10 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2012-07-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
Etanercept and Vascular Function in Psoriasis
NCT01989689 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels
NCT03932110 ·Status: COMPLETED ·Phase: NA
-
Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism
NCT03629639 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
NCT07102888 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Thalidomide in the Treatment of Chronic Plaque Psoriasis.
NCT01891019 ·Status: COMPLETED ·Phase: PHASE2
-
Can We Miss Pigmented Lesions in Psoriasis Patients?
NCT01053819 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Repeat Courses of IM Alefacept
NCT00233662 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Analysis of Small and Large Plaque Psoriasis
NCT01920906 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis
NCT01001208 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
NCT03791216 ·Status: COMPLETED
-
Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis
NCT04693936 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
NCT02239666 ·Status: COMPLETED
-
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
NCT07261306 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
NCT00161655 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
NCT01019200 ·Status: COMPLETED
-
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
NCT00683930 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis
NCT00808223 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
NCT00417820 ·Status: COMPLETED ·Phase: PHASE1
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
NCT00930384 ·Status: COMPLETED
-
Moderate to Severe Plaque Psoriasis With Scalp Involvement
NCT00791765 ·Status: COMPLETED ·Phase: PHASE4
-
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Effect of Long-term Psoriasis on Patients' Life - CORONATE
NCT05555953 ·Status: COMPLETED
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2